Awarded at the XXth World Vetrinary Poultry Association Congress in Edinburgh, vet and microbiologist Prof. Dr. Klaus Ã–sterrieder won the Innovation in Vaccination Award sponsored by Boehringer Ingelheim for his work in the development of the first genetic systems for Marek’s disease virus.
Awarded at the XXth World Vetrinary Poultry Association Congress in Edinburgh, vet and microbiologist Prof. Dr. Klaus Österrieder won the Innovation in Vaccination Award sponsored by Boehringer Ingelheim for his work in the development of the first genetic systems for Marek’s disease virus.
Dr. Klaus Österrieder’s credentials are sublime, he is a trained veterinarian and currently a Professor of Virlology at the Institut fur Virologie at the Freie Universitat in Germany whilst also being the Adjunct Professor of Virology at Cornell University.
Dr. Klaus Österrieder (left) with Antoine Laplat (centre) and Nigel Horrox WVPA President (right)
He is recognised as a world leader in the research on Marek’s disease virus (MDV) which causes deadly lymphoma and immunosuppression in chickens. One of his major contributions to the field has been the development of the first genetic systems for MDV (MDV BACs) which has allowed him and many other researchers worldwide to manipulate the virus genome and shed light on the pathogenesis of this deadly pathogen.
Antoine Laplat, Director, Strategic Marketing, Boehringer Ingelheim told The Poultry Site that “Dr. Österrieder’s research has helped massively in the development of new vaccines including their new Chimera vaccine.”
Dr. Österrieder’s laboratory not only developed genetic systems for MDV and several other veterinary and human herpesviruses, but also a mutagenesis system that allows the manipulation of the virus genome in a desired way.
The method “two-step red-mediated mutagenesis” developed by Dr. Österriederand his team has been widely used by both virologists and researchers in several disciplines and has been cited hundreds of times. Mr Laplat commended the practicality of Dr. Österrieder’s research saying that his background as a practising veterinarian is evident in the functionality of his research and the broad application it has on developing vaccines.